Literature DB >> 11313891

Sodium nitroprusside enhances TRAIL-induced apoptosis via a mitochondria-dependent pathway in human colorectal carcinoma CX-1 cells.

Y J Lee1, K H Lee, H R Kim, J M Jessup, D W Seol, T H Kim, T R Billiar, Y K Song.   

Abstract

The tumor necrosis factor-related apoptosis-inducing ligand (TRAIL, Apo-2L) is a recently characterized member of the family of programmed cell death-inducing ligands that includes TNF-alpha and CD95L (FasL). It is well known that TRAIL binds to the death signaling receptors, DR4 and DR5, and initiates the TRAIL death pathway. Activation of this pathway, mediated through a caspase cascade, causes apoptosis. In this study, we hypothesized that oxidative stress facilitates TRAIL-induced apoptosis by promoting caspase activity through cytochrome c release from mitochondria. Human colorectal carcinoma CX-1 cells were treated with various concentrations of TRAIL (12.5-200 ng/ml) and/or sodium nitroprusside (SNP; 0.03-1 mM) for 12 h. SNP, a nitric oxide donor, which had little toxic effect by itself, enhanced TRAIL-induced cytotoxicity. For example, TRAIL-induced apoptosis (200 ng/ml) was increased by a factor of 2.5-fold in the presence of 1 mM SNP. The combined treatment also caused an increase in cytochrome c release, caspase-3 activity, and PARP cleavage. Overexpression of Bcl-2 completely blocked the SNP-promoting effects, but only moderately inhibited TRAIL-induced apoptosis. Similar results were observed in the presence of hydrogen peroxide or peroxynitrite. Taken together, the present studies suggest that SNP enhances TRAIL-induced cytotoxicity by facilitating the mitochondria-mediated caspase signal transduction pathway.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11313891     DOI: 10.1038/sj.onc.1204225

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  9 in total

1.  Nimbolide sensitizes human colon cancer cells to TRAIL through reactive oxygen species- and ERK-dependent up-regulation of death receptors, p53, and Bax.

Authors:  Subash C Gupta; Simone Reuter; Kanokkarn Phromnoi; Byoungduck Park; Padmanabhan S Hema; Mangalam Nair; Bharat B Aggarwal
Journal:  J Biol Chem       Date:  2010-11-15       Impact factor: 5.157

2.  Hypoxia and low glucose differentially augments TRAIL-induced apoptotic death.

Authors:  Yong J Lee; Mi-Sun Moon; Seok J Kwon; Juong G Rhee
Journal:  Mol Cell Biochem       Date:  2005-02       Impact factor: 3.396

3.  Suppression of NF-kappa B survival signaling by nitrosylcobalamin sensitizes neoplasms to the anti-tumor effects of Apo2L/TRAIL.

Authors:  Mamta Chawla-Sarkar; Joseph A Bauer; Joseph A Lupica; Bei H Morrison; Zhuo Tang; Rhonda K Oates; Alex Almasan; Joseph A DiDonato; Ernest C Borden; Daniel J Lindner
Journal:  J Biol Chem       Date:  2003-07-24       Impact factor: 5.157

4.  Effects of interferon beta on transcobalamin II-receptor expression and antitumor activity of nitrosylcobalamin.

Authors:  Joseph A Bauer; Bei H Morrison; Ronald W Grane; Barbara S Jacobs; Sally Dabney; Ana M Gamero; Kevin A Carnevale; Daniel J Smith; Judith Drazba; Bellur Seetharam; Daniel J Lindner
Journal:  J Natl Cancer Inst       Date:  2002-07-03       Impact factor: 13.506

5.  Increased sensitivity to TRAIL-induced apoptosis occurs during the adenoma to carcinoma transition of colorectal carcinogenesis.

Authors:  A Hague; D J Hicks; F Hasan; H Smartt; G M Cohen; C Paraskeva; M MacFarlane
Journal:  Br J Cancer       Date:  2005-02-28       Impact factor: 7.640

6.  A novel role for SIRT-1 in L-arginine protection against STZ induced myocardial fibrosis in rats.

Authors:  Sherine M Rizk; Shohda A El-Maraghy; Noha N Nassar
Journal:  PLoS One       Date:  2014-12-12       Impact factor: 3.240

7.  Cerebrolysin Ameloriates Cognitive Deficits in Type III Diabetic Rats.

Authors:  Gehan S Georgy; Noha N Nassar; Hanaa A Mansour; Dalaal M Abdallah
Journal:  PLoS One       Date:  2013-06-19       Impact factor: 3.240

8.  AML1/ETO sensitizes via TRAIL acute myeloid leukemia cells to the pro-apoptotic effects of hypoxia.

Authors:  V Barbetti; I Tusa; M G Cipolleschi; E Rovida; P Dello Sbarba
Journal:  Cell Death Dis       Date:  2013-03-14       Impact factor: 8.469

9.  Study of molecular mechanisms of pro-apoptotic activity of NCX 4040, a novel nitric oxide-releasing aspirin, in colon cancer cell lines.

Authors:  Anna Tesei; Marco Rosetti; Paola Ulivi; Francesco Fabbri; Laura Medri; Ivan Vannini; Manlio Bolla; Dino Amadori; Wainer Zoli
Journal:  J Transl Med       Date:  2007-10-30       Impact factor: 5.531

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.